NEPHROS, INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
NEPHROS, INC. (NEPH) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $0 as of 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2019-03-12
- 2018-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $0.00.
- 2018-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $0.00.
- 2017-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $233.00K.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-12 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2017-12-31 | $233.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |